{
    "nctId": "NCT06315868",
    "briefTitle": "Breast Cancer Subtype Characterization Through Patient's Derived Organoids.",
    "officialTitle": "Breast Cancer Subtype Characterization Through Patient's Derived Organoids\". (BCinsightPDO)",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Organoids",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 306,
    "primaryOutcomeMeasure": "evaluate the histological and molecular conformity (yes/no) between PDO and matched primary and/or recurrent BC sample, in order to develop a live biobank of ER/PR+, HER2+ and TNBC PDO.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women diagnosed with primary BC, eligible for surgical resection of the tumor according to national and international guidelines.\n\nage between 18 and 70 years; newly diagnosed breast neoplasms, tumor size of at least 1.5 cm diameter.\n\nExclusion Criteria:\n\nbreast cancer diagnosed during pregnancy, neoadiuvant chemotherapy",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}